BioTechX USA 2025

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 2025 congress of BioTechX USA and present how Tempus leverages AI for RWE generation to support drug development.

Schedule a meeting with us→

TUE, SEP 16

3:30-3:50pm ETLIVELocation: Pennsylvania Convention Center 1101 Arch St, Philadelphia, PA 19107; Session Track: AI in Drug Development and Discovery

Closing the Loop: Integrating RWD, Organoids, & AI to Accelerate Preclinical Oncology

Explore the critical challenges hindering oncology R&D, from inefficient target discovery and data integration difficulties to the significant translational gap. Discover Tempus Loop, an innovative platform that seamlessly integrates real-world data (RWD), patient-derived organoids (PDOs), and advanced AI/ML to generate comprehensive, actionable insights. Explore a real-world example of how this integrated approach helped accelerate preclinical development, mitigate translational risk, and enhance analytical power. Add to calendar

Justin Guinney Senior Vice President of Cancer Genomics (Tempus)

Schedule a meeting with us

We'll be in touch shortly.